Welcome to today’s Five at Five – the EOB snapshot of the five most impactful market stories shaping investor sentiment.
1. Nvidia becomes first firm valued above $5 trillion
The chipmaker’s shares soared as investors doubled down on the AI boom, propelling Nvidia to an unprecedented valuation milestone. Read more …
2. Next delivers another ‘beat and raise’ update
The retailer once again lifted full-year guidance after outperforming in the third quarter, prompting analysts to declare its consistency unmatched. Read more …
3. GSK hikes outlook on strong quarterly performance
The pharmaceuticals group's outgoing CEO Emma Walmsley signed off by raising its forecasts after robust sales drove profit growth beyond expectations. Read more …
4. FTSE 100 lifted by miners and earnings from Next, GSK and Glencore
London’s blue-chip index climbed 59 points to reach another record closing high at 9,756.1, driven by strength in mining stocks and upbeat earnings. Read more …
5. EnergyPathways CEO discusses MESH project and growth focus
Chief executive Ben Clube outlines how the company’s MESH initiative integrates energy storage, hydrogen and graphite for future expansion. Watch here …
More small cap news
Seeing Machines Ltd (AIM:SEE, OTC:SEEMF) has signed a development deal with a leading Japanese carmaker. It’ll create AI-powered driver and passenger monitoring tech, with a full production contract expected in 2026. Read more
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) posted record quarterly results, driven by strong copper and cobalt royalties. Revenue more than doubled to $25 million, helped by higher output and a return to mining at Kestrel. Watch more
Astrid Intelligence PLC (AQSE:ASTR) has brought in AI entrepreneur Léo Mercier as its new Bittensor Strategist. He’ll lead development of Astrid’s decentralised AI network and boost innovation across its products and data operations. Read more
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) has cleared its shareholder debt after investors exercised £55 million in warrants. It’s also secured a new £50 million loan facility, giving it more flexibility to fund its allergy vaccine pipeline. Read more
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) has officially rebranded as CelLBxHealth plc. The new ticker CLBX starts trading today, marking a fresh chapter for the diagnostics company. Read more